- Report
- October 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- August 2025
- 150 Pages
Global
From €2543EUR$2,850USD£2,242GBP
€3435EUR$3,850USD£3,029GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2489EUR$2,789USD£2,194GBP
- Report
- September 2025
- 110 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- December 2024
- 70 Pages
Global
From €3565EUR$3,995USD£3,143GBP
- Report
- August 2025
- 199 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- September 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- November 2025
- 278 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- December 2024
- 30 Pages
Global
From €1963EUR$2,200USD£1,731GBP
€2454EUR$2,750USD£2,164GBP
- Report
- December 2024
- 30 Pages
Global
From €1963EUR$2,200USD£1,731GBP
€2454EUR$2,750USD£2,164GBP
- Report
- December 2024
- 30 Pages
Global
From €1963EUR$2,200USD£1,731GBP
€2454EUR$2,750USD£2,164GBP
- Report
- October 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- February 2025
- 135 Pages
Global
From €13380EUR$14,995USD£11,798GBP
- Report
- January 2024
- 150 Pages
Global
From €5309EUR$5,950USD£4,681GBP
- Report
- August 2022
- 120 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- April 2024
- 115 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- March 2024
- 200 Pages
Global
From €3703EUR$4,150USD£3,265GBP
- Report
- July 2024
- 150 Pages
Global
From €2677EUR$3,000USD£2,360GBP
€3346EUR$3,750USD£2,950GBP
- Report
- June 2024
- 200 Pages
Global
From €5675EUR$6,360USD£5,004GBP
€7094EUR$7,950USD£6,255GBP
- Report
- June 2023
- 200 Pages
Global
From €5354EUR$6,000USD£4,721GBP
€6692EUR$7,500USD£5,901GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more